Cargando…

Recurrent Acromegaly in a Patient With a CHEK2 Mutation

BACKGROUND/OBJECTIVE: CHEK2 is a cell-cycle checkpoint kinase and is part of the ATM-CHEK2-p53 cascade, which is protective against carcinogenesis. We describe a germline CHEK2 mutation in a patient with acromegaly and other tumors. CASE REPORT: We present a woman with a germline CHEK2∗ 110delC muta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perosevic, Milica, Martinez-Lage, Maria, Swearingen, Brooke, Tritos, Nicholas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association of Clinical Endocrinology 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984513/ https://www.ncbi.nlm.nih.gov/pubmed/35415223 http://dx.doi.org/10.1016/j.aace.2021.10.006

Ejemplares similares

Clinical Utility of Osilodrostat in Cushing’s Disease: Review of Currently Available Literature
por: Perosevic, Milica, et al.
Publicado: (2023)

Editorial: Personalized management of acromegaly
por: Tritos, Nicholas A.
Publicado: (2023)

Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly
por: Nachtigall, Lisa B, et al.
Publicado: (2020)

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021)

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
por: Koen, Kortbeek, et al.
Publicado: (2022)

CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report
por: Szeliga, Anna, et al.
Publicado: (2020)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures
por: Ow, Ghim Siong, et al.
Publicado: (2014)

The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study
por: Alorjani, Mohammed, et al.
Publicado: (2023)

Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
por: Gao, Yinjie, et al.
Publicado: (2021)

CHEK2 mutations in pediatric brain tumors
por: Tlais, Dana, et al.
Publicado: (2023)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors
por: Kinget, Lisa, et al.
Publicado: (2021)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou, Panagiotis, et al.
Publicado: (2017)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

Multiple Primary Melanoma in a CHEK2 Mutation Carrier
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2023)

Inherited CHEK2 p.H371Y mutation in solitary rectal ulcer syndrome among familial patients: A case report
por: He, Cheng-Cheng, et al.
Publicado: (2023)

A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression
por: Leporati, Paola, et al.
Publicado: (2015)

A case report of biallelic CHEK2 heterozygous variant presenting with breast cancer
por: Soleimani, Tahereh, et al.
Publicado: (2023)

Multiple Myeloma in a Patient with Acromegaly
por: Kang, Yu Mi, et al.
Publicado: (2015)

Acromegaly in pregnancy
por: Koshy, T. George, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Clinical relevance of CHEK2 and NBN mutations in the macedonian population
por: Kostovska, I Maleva, et al.
Publicado: (2015)

Genomic Breakpoints’ Characterization of a Large CHEK2 Duplication in an Italian Family with Hereditary Breast Cancer
por: Germani, Aldo, et al.
Publicado: (2022)

A novel mutation in PRKAR1A gene in a patient with Carney complex presenting with pituitary macroadenoma, acromegaly, Cushing's syndrome and recurrent atrial myxoma
por: Ghazi, Ali A., et al.
Publicado: (2021)

Recurrent cardiac and skin myxomas along with acromegaly: A case report of carney complex
por: Shirinpour, Zivar, et al.
Publicado: (2020)

Acromegaly in preadolescence: A case report of a 9-year-old boy with acromegaly
por: Mbadugha, Tobechi, et al.
Publicado: (2020)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007)

Rosiglitazone as an option for patients with acromegaly: a case series
por: Tamez-Pérez, Héctor E, et al.
Publicado: (2011)

Bone Augmentation Procedures in a Patient with Acromegaly
por: Schiller, Laura Andreea, et al.
Publicado: (2020)

The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation
por: Li, Xueen, et al.
Publicado: (2022)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Psychotic symptoms in acromegaly
por: Pinto, Denzil, et al.
Publicado: (2005)

Pachydermoperiostosis Masquerading as Acromegaly
por: Karimova, Munira M., et al.
Publicado: (2017)

CHEK2 (∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014)

Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports
por: Li, Qiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d6pqia1jah9t3pn70p53ia29mb